Lacharon, Ethal Ralf .

HRN: 21-45-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
CEFTRIAXONE 1G (VIAL)
06/15/2022
06/21/2022
IV
800mg
Q24
PCAP C
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: